The study of post-translational modifications such as protein lipidation is a non-trivial challenge of the postgenomic era. In recent years the field of chemical proteomics has greatly advanced our ability to identify and quantify protein lipidation. In the present review, we give a brief overview of the tools available to study protein acylation, prenylation and cholesterylation, and their application in the identification and quantification of protein lipidation in health and disease.
Introduction
PTMs (post-translational modifications) of proteins include a host of chemical transformations that occur to proteins after (or occasionally during) ribosomal synthesis. A large number of reversible and irreversible PTMs serve to regulate protein function, activity and location within the cell. As PTMs are not directly encoded by the genome, they add a further layer of complexity to the proteome that is not readily accessible to the traditional tools of genetics. PTMs include the covalent attachment of small inorganic molecules (e.g. phosphorylation), carbohydrates (e.g. glycosylation), small proteins (e.g. ubiquitination) and lipids. Protein lipidation includes, among others, N-myristoylation [1] , S-and N-palmitoylation [2] , prenylation [3] , cholesterylation [4] and the attachment of GPI (glycosylphosphatidylinositol) anchors [5] (Figure 1 ).
The importance of protein lipidation in normal and dysfunctional cell regulation is mirrored in current programmes that aim to develop therapies targeting lipidation [6] [7] [8] . Modulating or inhibiting lipidation has an impact on a range of pathologies, including cancer, cardiovascular disease, fungal infections and tropical diseases such as malaria, as well as HIV and AIDS [1, 9, 10] .
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months of exposure time to obtain results. The development of chemical proteomics [11] in recent years has revolutionized the study of PTMs, in particular protein lipidation [1, 11, 12] . New chemical tools and techniques now allow the facile and rapid detection, identification and quantification of protein lipidation in a matter of days [11, 12] .
In the present review, we cover the basic principles of chemical proteomics in the study of protein acylation, prenylation and cholesterylation, as well as recent advances in quantitative methods to study these PTMs.
Introducing a chemical handle on lipidated proteins
The most widely applicable chemical method for labelling and isolating lipidated proteins involves metabolic labelling in cultured cells or enzymatic labelling in vitro with an alkyne or azide-tagged lipid analogue [11] [12] [13] [14] [15] [16] [17] [18] [19] (Figure 2 [11, 12, 16] . The proteins can subsequently be visualized by gel-based methods or enriched by affinity purification. The enriched lipidated proteome can be analysed by state-of-theart MS. By this method, in excess of 400 lipidated proteins can be identified in a single experiment [20, 21] .
Metabolic labelling with lipid analogues is applicable to each of the lipid PTMs discussed above. In addition, several other methods such as ABE (acyl/biotin exchange) and acyl-RAC (resin-assisted capture) have been developed for the study of protein palmitoylation and will be further detailed in the following sections. 
Protein acylation: myristoylation and palmitoylation
Myristoylation and palmitoylation are the attachment of a myristate (C 14:0 ) or palmitate (C 16:0 ) fatty acid chain respectively. Myristoylation, catalysed by N-myristoyltransferase (NMT1 and NMT2 in humans), occurs on an N-terminal glycine residue to from an amide bond, either co-or post-translationally [1] . Palmitoylation, on the other hand, is a reversible dynamic process controlled by both palmitoyl acyltransferase and palmitoyl thioesterase enzymes [22] . The palmitate moiety is attached to one or more internal cysteine residues via a thioester bond. In some instances N-palmitoylation, resulting in an amide bond, is caused by the rearrangement from an S-palmitoylated residue [2] . Our group has pioneered the use of chemical tools to study protein N-myristoylation through metabolic labelling using azido-and alkynyl-tagged myristic acid analogues [15] [16] [17] . The myristic acid analogues are recognized by acylCoA synthase and converted into the corresponding CoAthioesters, which then functions as a substrate for NMT [16] . The chemical tag introduced on myristoylated proteins enables visualization of the myristome by gel-based methods, as well as enrichment for immunoblotting or proteomic analysis [23, 24] .
Previous studies have focused on methods to identify and quantify dynamic protein palmitoylation (Table 1) . Similarly to myristoylation, palmitoylated proteins can be detected by azido or alkyne-derivitized palmitoyl analogues [14, 19, 25] . Martin and Cravatt [26] along with other groups in the field pioneered the use of 17-ODYA (17-octadecynoic acid) for metabolic labelling of palmitoylated proteins.
The labile nature of the S-palmitoyl-cysteine thioester bond presents challenges but also advantages in the detection of palmitoylated proteins that are not encountered for other forms of protein lipidation. A number of analytical techniques including ABE [27] [28] [29] , acyl-RAC, [30] and iFAT (isotope-coded fatty acid transmethylation) [31] exploit the labile nature of the palmitate-cysteine thioester bond, and involve chemical transformation of the native proteome only after cell or tissue lysis. In ABE and acyl-RAC, free thiols are capped, followed by cleavage of the palmitoyl thioester bond by hydroxylamine to expose a free thiol group. In ABE the free thiol is coupled to a biotin group, allowing enrichment on streptavidin resin. In the acyl-RAC protocol, the protein sample is instead incubated with a thiolreactive resin, allowing capture and enrichment to proceed in one step. Although powerful, relying solely on thiol and thioester chemistry to label targets results in relatively high background (particularly in more complex systems) and loss of any information on the identity of the species (lipid or otherwise) previously bound via a thioester.
In iFAT, proteins are separated by SDS/PAGE, stained and each band excised before subsequent processing. Each band is subjected to base-catalysed transmethylation with isotopically labelled methanol to generate the fatty acid ester, which is subsequently extracted and identified by MS. In contrast with ABE and acyl-RAC, which aim to identify the palmitoylated protein and cannot give any information about the fatty acid modification, iFAT allows the identification and quantification of the modifying fatty acid [31] . Further elaboration of the iFAT protocol, such as immunopurification before transmethylation, would be required to allow assignment of a particular lipid to a specific protein.
ABE has been widely used to study protein palmitoylation in a range of biological systems, e.g. yeast [28] , murine [29] , human [32, 33] and African trypanosomes [34] . A recent report from the Rayner group [21] presented a comprehensive study of protein palmitoylation in Plasmodium falciparum. Analysis of late-stage asexual parasites cultured in human erythrocytes using a combination of ABE and metabolic labelling with 17-ODYA enabled the detection of more than 400 palmitoylated proteins. This report presents an interesting side-by-side comparison of the two most commonly used techniques for detecting protein palmitoylation. Each technique detected a unique pool of proteins, with an overlap of approximately 50%. More proteins were detected by ABE, but this technique was also associated with higher background.
Prenylation and cholesterylation
Protein prenylation, the attachment of a farnesyl (C 15 ) or geranylgeranyl (C 20 ) isoprenoid to one or more cysteine residues located near the C-terminus, are PTMs that modulate protein cellular localization, signalling and degradation [3] . The transfer is catalysed by a dedicated transferase enzyme, FTase (farnesyltransferase) or GGTase-1 (geranylgeranyltransferase type I), GGTase-2/RabGGTase (geranylgeranyltransferase type II) from a pyrophosphate prenyl donor. The prenyl tail allows proteins to localize to the cell membrane where they can exert their function and interact with downstream effectors. Many key members of the Ras superfamily of proteins, including Rho and Rab GTPases, require prenylation for correct function. As several cancers are associated with dysfunctional Ras signalling, prenyltransferase inhibitors have received much attention as potential anticancer treatments [10, 35] .
Several laboratories [18, 24, 36, 37] , including our own [13] , have described the use of chemical reporters to detect and identify prenylated proteins. Two different strategies are generally employed: first, metabolic labelling using prenyl alcohols in cell culture; or secondly, in vitro prenylation with prenyl pyrophosphates using recombinant transferases in cell lysate or tissue homogenate. The prenyl alcohols are taken up by cells in culture and converted into their pyrophosphate equivalent through a poorly characterized isoprenoid salvage pathway [38] . For adequate incorporation of prenyl probes, pre-and/or co-treatment with statins is commonly required. Farnesyl and geranylgeranyl pyrophosphate are intermediates of cholesterol biosynthesis, and hence statin treatment leads to depletion of endogenous isoprenoids by inhibiting the rate-limiting enzyme of the mevalonate pathway, HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase. Labelling of the prenylated proteome is hence limited by the activity of the prenyl alcohol salvage pathway and competition with pools of endogenous isoprenoids. Statin treatment, however, has multiple effects in the cell including altered expression of several prenylated proteins [39] .
The differential detection of farnesylated compared with geranylgeranylated proteins has not yet been quantitatively accessed with currently available chemical tools. Reported probes are either non-selective or suitable for specific detection of geranylgeranylation. Several studies suggest that the prenylation state of e.g. RhoB, a protein that can be either fanesylated or geranylgeranylated, promotes different functions in the cell and affects cellular localisation [9] . Furthermore, it has been suggested that proteins normally farnesylated, e.g. Ras proteins, are geranylgeranylated in the presence of FTIs (FTase inhibitors), and this may in part explain the failure of FTIs to translate from promising anticancer drugs in cell studies to useful agents in the clinic [10, 35] .
Protein cholesterylation is a PTM required for the function and signalling of Hh (Hedgehog) proteins [4] . Misregulated Hh signalling is implicated in a number of cancers, including pancreatic carcinoma and lung adenocarcinoma. Our group recently reported the first chemically tagged probe for probing protein cholesterylation in live cells [14] . This probe labels Shh (Sonic Hh) proteins transiently overexpressed in HEK (human embryonic kidney)-293A cells and carcinoma cell lines. In-gel fluorescence analysis of the cholesterylated proteome also indicated that a number of other proteins may be labelled by the cholesterol probe, but their identity has yet to be established. Furthermore, the same paper reported the first example of tagging both Shh N-palmitoylation and O-cholesterylation in the same cell by metabolic labelling with a combination of mutually compatible palmitate and cholesterol probes.
Quantification of protein lipidation
A steady stream of reports published in the last few years has presented novel methodologies and their application to identify and quantify lipidated proteins. This development has been greatly facilitated by concurrent advances in sophisticated MS, and its increasingly widespread availability. Current technology has sufficient resolution power to identify and quantify in excess of 10 000 proteins from complex mixtures such as cell or tissue lysates [40] .
In recent years, quantitative proteomic techniques such as SILAC (stable isotope labelling by amino acids in cell culture) [41] have been used in combination with chemical proteomics to quantify protein lipidation. The combination of these techniques presents exciting opportunities to understand changes in protein lipidation in response to disease, drugs and treatment, as well as changes in other metabolic and signalling pathways in the cell. Furthermore, quantification can be used as a means to assess signal/background ratios and validate proteomics hits [20, 21] . Although these technologies can be costly to implement, the increased value of the data in terms of systems modelling will result in increasingly widespread use of SILAC or other quantitative approaches in combination with chemical tagging. A useful variation on this theme is spike-in SILAC [42] , recently developed by the Mann group, which may find application in the quantification of protein lipidation.
In cases where the use of SILAC is impractical or not feasible, such as in vivo or in primary cell culture where the stability of the cell phenotype is limited to a few passages, other quantitative methods such as isobaric tagging [e.g. iTRAQ (isobaric tags for relative and absolute quantification)] or ICAT (isotope-coded affinity tag) can prove useful. For example, ICAT has been applied to survey the targets of palmitoyl acyltransferase DHHC2 [43] .
Challenges in the field and future perspectives
Whereas great advances have been made in the study of protein lipidation in vitro and in cell culture, only a few groups have reported the use of chemical probes to study in vivo systems, for example by metabolic labelling with ω-alkynyl-palmitate [44] or in vitro prenylation of tissue lysates [13] . Metabolic labelling in mammals has not yet provided comprehensive or reliable profiling of targets, and further studies will be required to understand whether attendant pharmacokinetic issues (bioavailability/distribution, metabolism and toxicity) can be overcome. However, it seems plausible that certain compartments of an in vivo model would be relatively accessible to metabolic labelling probes, at least over a limited timeframe, for example by direct introduction into the bloodstream or injection into specific organ or xenograft tissue. Although limited to analysis of S-acylation, protocols such as ABE/acyl-RAC may be more applied straightforwardly to in vivo studies as all downstream processing steps are carried out in vitro.
To date, there has been little focus on studying the metabolism of the lipid analogues used in labelling studies, and the assumption is commonly made that the proteins identified are modified by the probes used for labelling, and not their metabolites. A recent report suggests that metabolism of analogues does indeed occur, as one would expect for a biomimetic substrate, and that metabolism may also be monitored using the chemical tag [45] . In the present article, tools to identify both the site of modification and the modifying lipid species would be hugely beneficial, for example using capture-release reagents to aid recovery and analysis of the modified peptide that is otherwise lost in the enrichment step [46] .
The field of chemical proteomics is revolutionizing the study of protein lipidation. Although great advances have been made, many exciting opportunities to develop new tools and better analytical methodologies exist. Equally, efforts are ongoing to expand application of the tools already at hand to broaden our understanding of the function and regulation of protein lipidation, and the potential to target it for therapeutic benefit. 
